drugset / Trial / NCT03973021
Very Small Embryonic-like Stem Cells for Erectile Dysfunction
Phase 1/2
Withdrawn
Fuda Cancer Hospital, Guangzhou
Guangzhou Four-Leaf Clover HealthTech Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to organic erectile dysfunction, such as those associated with metabolic syndrome or the treatment of prostate cancer.
Timeline
- Start
- 2019-07-01
- Primary completion
- 2020-05-20
- Completion
- 2020-07-01
Outcome
Outcome not reported
Stopped: “Policy changes have contributed to the failure to carry out smoothly”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Very small embryonic-like stem cell(VSEL) | Cell therapy | 60000 cells | Other |
| Subject | Very small embryonic-like stem cell(VSEL) | Cell therapy | 90000 cells | Other |
| Subject | Very small embryonic-like stem cell(VSEL) | Cell therapy | 120000 cells | Other |